A detailed history of Bank Of New Hampshire transactions in Novartis Ag stock. As of the latest transaction made, Bank Of New Hampshire holds 255 shares of NVS stock, worth $24,770. This represents 0.01% of its overall portfolio holdings.

Number of Shares
255
Previous 255 -0.0%
Holding current value
$24,770
Previous $27,000 7.41%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 04, 2023

SELL
$80.03 - $92.81 $1,200 - $1,392
-15 Reduced 5.56%
255 $23,000
Q3 2022

Oct 24, 2022

BUY
$74.61 - $87.26 $8,580 - $10,034
115 Added 74.19%
270 $21,000
Q1 2022

Apr 20, 2022

BUY
$80.11 - $90.62 $12,417 - $14,046
155 New
155 $14,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.